Financials

News Ideas Technicals Forecast

KROS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Keros Therapeutics, Inc.

Total assets of KROS for Q4 23 is 370.02 M USD, 13.42% more than the previous Q3 23. And total liabilities increased by 24.36% in Q4 23 to 37.81 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—